Muhlenkamp & Co Portfolio holdings
Top Buys
| 1 |
Direxion Daily S&P 500 Bear 1X ETF
SPDN
|
+$10.6M |
| 2 |
SPDR Gold Trust
GLD
|
+$617K |
| 3 |
Royal Gold
RGLD
|
+$471K |
| 4 |
Franco-Nevada
FNV
|
+$360K |
| 5 |
SLB Ltd
SLB
|
+$144K |
Top Sells
| 1 |
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
|
+$1.45M |
| 2 |
Pfizer
PFE
|
+$1.27M |
| 3 |
Morgan Stanley
MS
|
+$822K |
Sector Composition
| 1 | Energy | 21.74% |
| 2 | Healthcare | 20.15% |
| 3 | Technology | 12.91% |
| 4 | Industrials | 10.12% |
| 5 | Consumer Discretionary | 8.54% |
Similar funds
Muhlenkamp & Co's Q3 2022 Portfolio in Review
As of Q3 2022, Muhlenkamp & Co held 29 positions worth $224M, up 4.9% from $214M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Muhlenkamp & Co deployed $9.55M of net new capital in Q3 2022, opening 1 new position and adding to 22 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 652,921 shares worth $11.7M.
By sector, the portfolio is most concentrated in Energy at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Tenneco Inc. Class A Voting Common Stock, an estimated $1.45M trimmed.
- Muhlenkamp & Co's largest Q3 2022 buy was Direxion Daily S&P 500 Bear 1X ETF: 652,921 shares worth $11.7M.
- Muhlenkamp & Co added most to SPDR Gold Trust in Q3 2022, an estimated $617K increase.
- Muhlenkamp & Co's biggest Q3 2022 reduction was Tenneco Inc. Class A Voting Common Stock, cutting an estimated $1.45M.
- Muhlenkamp & Co fully exited Pfizer in Q3 2022, selling an estimated $1.27M.
- Muhlenkamp & Co's ten largest holdings make up 55% of its $224M portfolio in Q3 2022.
- Muhlenkamp & Co opened 1 new position and closed 2 in Q3 2022.
- Muhlenkamp & Co's portfolio value rose 4.9% quarter-over-quarter to $224M.
Based on Muhlenkamp & Co's 13F filing for Q3 2022, filed 1 Nov 2022.